Patients with T2D were examined by [ 68 Ga]Ga-DO3A-Tuna-2 and [ 68 Ga]Ga-DO3A-Exendin4 by PET, to assess the GCGR in liver and GLP1R in pancreas, respectively
GLP1 therapies represent an important area of focus for us, and we will continue working toward building a fullbreadth portfolio for multiple metabolic indications across all formats, he added.
Sarwer, director of the Center for Obesity Research and Education in the Barnett College of Public Health at Temple University, told Flow Space A lot of these things can be multifactorial. With that said, here are seven unusual side effects of GLP-1 drugs
Available treatments such as levodopa, dopamine agonists and monoamine oxidase B inhibitors offer only symptomatic relief however, they do not treat the underlying neurodegeneration, emphasising the need for neuroprotective management